Role of nitric oxide in angiogenesis and microcirculation in tumors

Cancer and Metastasis Reviews

Volumn 17, Issue 1, 1998, Pages 77-89

  Fukumura, Dai ^a   Jain, Rakesh K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Angiogenesis; Leukocyte endothelial interaction; Microcirculation; NO; Permeability; Tumor

Indexed keywords

N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANGIOGENESIS; ANIMAL CELL; BLOOD VESSEL PERMEABILITY; HUMAN; HUMAN CELL; MICROCIRCULATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SECOND MESSENGER; TUMOR BLOOD FLOW; TUMOR GROWTH; TUMOR VASCULARIZATION; VASODILATATION;

ANIMALS; CAPILLARY PERMEABILITY; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

EID: 0031925590     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005908805527     Document Type: Review

References (68)

1. Ignaro LJ: Endothelium-derived nitric oxide: actions and properties. FASEB J 3: 31-36, 1989
2. Nathan C: Nitric oxide as a secretory product of mammalian cells. FASEB J 6: 3051-3064, 1992
3. Moncada S: The L-arginine: nitric oxide pathway. Acta Physiol Scand 145: 201-227, 1992
4. Schmidt HHHW, Walter U: NO at work. Cell 78: 919-925, 1994
5. Nathan C, Xie Q-W: Nitric oxide synthases: Roles, tolls, and controls. Cell 78: 915-918, 1994
6. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1: 27-31, 1995
7. Fidler IJ, Ellis LM: The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 79: 185-188, 1994
8. Folkman J: Tumor angiogenesis. In: Mendelsohn J, Howley PM, Israel MA, Liotta LA (eds) The Molecular Basis of Cancer. WB Saunders, Philadelphia, 1995, pp 206-232
9. Ziche M, Morbidelli E, Masini E, Granger H, Geppetti P, Ledda F: Nitric oxide promotes DNA synthesis and cyclic GMP formation in endothelial cells from postcapillary venules. Biochem Biophys Res Commun 192: 1198-1203, 1993
10. Ziche M, Morbidelli L, Masini E, Amerini S, Granger HJ, Maggi CA, Geppetti P, Ledda F: Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest 94: 2036-2044, 1994
11. Morbidelli L, Chang C-H, Douglas JG, Granger HJ, Ledda F, Ziche M: Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. Am J Physiol 39: H411-H415, 1996
12. Pipili-Synetos E, Papageorgiou A, Sakkoula E, Sotiropoulou G, Fotsis T, Karakiulakis G, Maagoudakis ME: Inhibition of angiogenesis, tumor growth and metastasis by the NO-releasing vasodilators, isosorbide mononitrate and dinitrate. Br J Pharmacol 116: 1829-1834, 1995
13. Leibovich SJ, Polverini PJ, Fong TW, Harlow LA, Koch AE: Production of angiogenic activity by human monocytes requires an L-arginine/nitric oxide-synthase-dependent effector mechanism. Proc Natl Acad Sci USA 91: 4190-4194, 1994
14. Jenkins DC, Charles IG, Thomson LL, Moss DW, Holmes LS, Baylis SA, Rhodes P, Westmore K, Emson PC, Moncada S: Role of nitric oxide in tumor growth. Proc Natl Acad Sci USA 92: 4392-4396, 1995
15. Hudlicka O, Brown MD, Silgram H: Role of nitric oxide in capillary proliferation in chronically stimulated rat skeletal muscle. Int J Microcirc 16(S1): 92, 1996
16. Pipili-Synetos E, Sakkoula E, Maagoudakis ME: Nitric oxide is involved in the regulation of angiogenesis. Br J Pharmacol 108: 855-857, 1993
17. Pipili-Synetos E, Sakkoula E, Haralabopoulos G, Andriopoulou P, Peristeris P, Maagoudakis ME: Evidence that nitric oxide is an endogenous antiangiogenic mediator. Br J Pharmacol 111: 894-902, 1994
18. Andrade SP, Hart IR, Piper PJ: Inhibition of nitric oxide synthase selectively reduces flow in tumour-associated neovasculature. Br J Pharmacol 107: 1092-1095, 1992
19. 6-nitro-L-arginine. Cancer Res 54: 6458-6463, 1994
20. Tozer GM, Prise VE, Bell KM: The influence of nitric oxide on tumour vascular tone. Acta Oncologica 34: 373-377, 1995
21. Meyer RE, Shan S, DeAngelo J, Dodge RK, Bonaventura J, Ong ET, Dewhirst MW: Nitric oxide synthase inhibition irreversibly decreases perfusion in the R3230AC rat mammary adenocarcinoma. Br J Cancer 71: 1169-1174, 1995
22. Fukumura D, Yuan F, Endo M, Jain RK: Role of nitric oxide in tumor microcirculation: Blood flow, vascular permeability, and leukocyte-endothelial interactions. Am J Pathol 150: 713-725, 1997
23. Hahn JS, Braun RD, Dewhirst MW, Shan S, Snyder SA, Taube JM, Ong ET, Rosner GL, Dodge RK, Bonaventura J, Bonaventura C, DeAngelo J, Meyer RE: Stroma-free human hemoglobin A decreases R3230 Ac rat mammary adenocarcinoma blood flow and oxygen partial pressure. Radiat Res 147: 185-194, 1997
24. Tozer GM, Prise VE, Bell KM, Dennis MF, Stratford MR, Chaplin DJ: Reduced capacity of tumour blood vessels to produce endothelium-derived relaxing factor: significance for blood flow modification. Br J Cancer 74: 1955-1960, 1996
25. Tozer GM, Prise VE, Chaplin DJ: Inhibition of nitric oxide synthase induces a selective reduction in tumor blood flow that is reversible with L-arginine. Cancer Res 57: 948-955, 1997
26. Jain RK: Determinants of tumor blood flow: A review. Cancer Res 48: 2641-2658, 1988
27. Warren BA in: H-I Peterson (ed.) The Vascular Morphology of Tumors. CRC Press, Inc., Boca Raton, pp 1-48, 1979
28. Tanda S, Patan S, Roberge S, Jones RC, Jain RK: Distribution of contractile elements in tumor vessels. Int J Microcirc Clin Exp 16(S1): 150, 1996
29. Barnes PJ: Cyclic nucleotides and phosphodiesterases and airway function. Eur Respir J 8: 457-462, 1995
30. Holzman A, Block KD, Sanchez LS, Filippov G, Zapol WM: Hyporesponsiveness to inhaled nitric oxide in isolated, perfused lungs from endotoxin-challenged rats. Am J Physiol 271: L981-L986, 1996
31. Kubes P: Nitric oxide affects microvascular permeability in the intact and inflamed vasculature. Microcirculation 2: 235-244, 1995
32. Kubes P, Granger D: Nitric oxide modulates microvascular permeability. Am J Physiol 262: H611-H615, 1992
33. Filep JG, Földes-Filep E: Modulation by nitric oxide of platelet-activating factor-induced albumin extravasation in the conscious rat. Br J Pharmacol 110: 1347-1352, 1993
34. Yuan Y, Granger HJ, Zawieja DC, DeFily DV, Chilian WM: Histamine increases venular permeability via a phospholipase C-NO synthase-guanylate cyclase cascade. Am J Physiol 264: H1734-H1739, 1993
35. Maeda H, Noguchi Y, Sato K, Akaike T: Enhanced vascular permeability in solid tumor is mediated by nitric oxide and inhibited by both new nitric oxide scavenger and nitric oxide synthase inhibitor. Jpn J Cancer Res 85: 331-334, 1994
36. Doi K, Akaike T, Horie H, Noguchi Y, Fujii S, Beppu T, Oguwa M, Maeda H: Excessive production of nitric oxide in rat solid tumor and its implication in rapid tumor growth. Cancer 77: 1598-1604, 1996
37. Wu HM, Huang O, Yuan Y, Granger HJ: VEGF induces NO-dependent hyperpermeability in coronary venules. Am J Physiol 271: H2735-2739, 1996
38. G-nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, ameliorates interleukin 2-induced capillary leakage and reduces tumour growth in adenocarcinoma-bearing mice. Br J Cancer 73: 189-196, 1996
39. Boughton-Smith NK, Evans SM, Laszlo F, Whittle BJR, Moncada S: The induction of nitric oxide synthase and intestinal vascular permeability by endotoxin in the rat. Br J Pharmacol 110: 1189-1195, 1993
40. Fujii E, Irie K, Uchida Y, Tsukahara F, Muraki T: Possible role of nitric oxide in 5-hydroxytryptamine-induced increase in vascular permeability in mouse skin. Naunyn-Schmiedeberg's Arch Pharmacol 350: 361-364, 1994
41. Ramírez MM, Quardt SM, Kim D, Oshiro H, Minnicozzi M, Durán WN: Platelet activating factor modulates microvascular permeability through nitric oxide synthesis. Microvasc Res 50: 223-234, 1995
42. Nakano S, Matsukado K, Black KL: Increased brain microvessel permeability after intracarotid bradykinin infusion is mediated by nitric oxide. Cancer Res 56: 4027-4031, 1996
43. Noel AA, Hobson RWI, Durán WN: Platelet-activating factor and nitric oxide mediate microvascular permeability in ischemia-reperfusion injury. Microvasc Res 52: 210-220, 1996
44. Jain RK: Transport of molecules across tumor vasculature. Cancer Metastasis Rev 6: 559-593, 1987
45. Yuan F, Leunig M, Berk DA, Jain RK: Microvascular permeability of albumin, vascular surface area, and vascular volume measured in human adenocarcmoma LS174T using dorsal chamber in SCID mice. Microvasc Res 45: 269-289, 1993
46. Ferrara N, Davis-Smyth T: The biology of vascular endothelial growth factor. Endocrine Rev, in press
47. Matsumura Y, Kimura M, Yamamoto T, Maeda H: Involvement of the kinin-generating cascade in enhanced vascular permeability in tumor tissue. Jpn J Cancer Res 79: 1327-1334, 1988
48. Ettinghausen SE, Puri RJ, Rosenberg SA: Increased vascular permeability in organs mediated by the systemic administration of lymphokine-activated killer cells and recombinant inlerleukin-2 in mice. J Natl Cancer Inst 80: 177-187, 1988
49. Yuan F, Salehi HA, Boucher Y, Vasthare US, Tuma RF, Jain RK: Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial window. Cancer Res 54: 4564-4568, 1994
50. Dvorak HF, Brown LF, Detmar M, Dvorak AM: Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146: 1029-1039, 1995
51. Fukumura D, Salehi HA, Witwer B, Tuma RF, Melder RJ, Jain RK: Tumor necrosis factor α-induced leukocyte adhesion in normal and tumor vessels: Effect of tumor type, transplantation site, and host strain. Cancer Res 55: 4824-4829, 1995
52. Melder RJ, Koenig GC, Witwer BP, Safabakhsh N, Munn LL, Jain RK: During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium. Nat Med: 992-997, 1996
53. Jain RK, Koenig GC, Dellian M, Fukumura D, Munn LL, Melder RJ: Leukocyte-endothelial adhesion and angiogenesis in tumors. Cancer Metastasis Rev 15: 195-204, 1996
54. Davenpeck KL, Gauthier TW, Lefer AM: Inhibition of endothelial-derived nitric oxide promotes P-selectin expression and actions in the rat microcirculation. Gastroenterology 107: 1050-1058, 1994
55. Kubes P, Suzuki M, Granger DN: Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 88: 4651-4655, 1991
56. Catarina RD, Libby P, Peng H-B, Thannickal VJ, Rajavashisth TB, Gimbrone MAJ, Shin WS, Liao JK: Nitric oxide decreases cytokine-induced endothelial activation. J Clin Invest 96: 60-68, 1995
57. Dellian M, Witwer BP, Salehi HA, Yuan F, Jain RK: Quantitation and physiological characterization of angiogenic vessels in mice: Effect of basic fibroblast growth factor, vascular endothelial growth factor/vascular permeability factor, and host microenvironment. Am J Pathol 149: 59-72, 1996
58. Buttery LDK, Spingall DR, Andrade SP, Riveros-Moreno V, Hart I, Piper PJ, Polak JM: Induction of nitric oxide synthase in the neo-vasculature of experimental tumors in mice. J Pathol 171: 311-319, 1993
59. Thomsen LL, Lawton FG, Knowles RG, Beesley JE, Riveros-Moreno V, Moncada S: Nitric oxide synthase activity in human gynecological cancer. Cancer Res 54: 1352-1354, 1994
60. Thomsen LL, Miles DW, Happerfield L, Bobrow LG, Knowles RG, Moncada S: Nitric oxide synthase activity in human breast cancer. Br J Cancer 72: 41-44, 1995
61. Kristensen CA, Roberge S, Jain RK: Effect of tumor necrosis factor a on vascular resistance, nitric oxide production, and glucose and oxygen consumption in perfused tissue-isolated human melanoma xenografts. Clin Cancer Res 3: 319-324, 1997
62. Cobbs CS, Brenman JE, Aldape KD, Bredt DS, Israel MA: Expression of nitric oxide synthase in human central nervous system tumors. Cancer Res 55: 727-730, 1995
63. Takahashi M, Fukuda K, Ohata T, Sugimura T, Wakabayashi K: Increased expression of inducible and endothelial constitutive nitric oxide synthases in rat colon tumors induced by azoxymethane. Cancer Res 57: 1233-1237, 1997
64. Fukumura D, Yonei Y, Kurose I, Saito H, Higuchi H, Miura S, Kato S, Kimura H, Ebinuma H, Ishii H: Role of nitric oxide in Kupffer cell-mediated hepatoma cell cytotoxicity in vitro and in vivo. Hepatology 24: 141-149, 1996
65. Xie K, Huang S, Dong Z, Juang S-H, Wang Y, Fidler IJ: Destruction of bystander cells by tumor cells transfected with inducible nitric oxide (NO) synthase gene. J Natl Cancer Inst 89: 421-427, 1997
66. Huang PL, Dawson TM, Bredt DS, Snyder SH, Fishman MC: Targeted disruption of neuronal nitric oxide synthase gene. Cell 75: 1273-1286, 1993
67. Huang PL, Huang Z, Mashimo H, Block KD, Moskowitz MA, Beven JA, Fishman MC: Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377: 239-242, 1995
68. MacMicking JD, Nathan C, Horn G, Chartrain N, Fletcher DS, Trumbauer M, Stevens K, Xie Q-W, Sokol K, Hutchinson N, Chen H, Mudgett JS: Altered responses to bacterial infection and endotoxin shock in mice lacking inducible nitric oxide synthase. Cell 81: 641-650, 1995